Erratum: Factors Associated with Adherence to Immunosuppressive Therapy and Barriers in Asian Kidney Transplant Recipients [Corrigendum].

IF 6.2 Q1 IMMUNOLOGY ImmunoTargets and Therapy Pub Date : 2020-09-14 eCollection Date: 2020-01-01 DOI:10.2147/ITT.S258315

引用次数: 1

Abstract

[This corrects the article DOI: 10.2147/ITT.S212760.].

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

更正:亚洲肾移植受者坚持免疫抑制治疗和障碍的相关因素[更正]。

[这更正了文章DOI: 10.2147/ITT.S212760.]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

ImmunoTargets and Therapy IMMUNOLOGY-

CiteScore

16.50

自引率

0.00%

发文量

审稿时长

16 weeks

期刊介绍： Immuno Targets and Therapy is an international, peer-reviewed open access journal focusing on the immunological basis of diseases, potential targets for immune based therapy and treatment protocols employed to improve patient management. Basic immunology and physiology of the immune system in health, and disease will be also covered.In addition, the journal will focus on the impact of management programs and new therapeutic agents and protocols on patient perspectives such as quality of life, adherence and satisfaction.

期刊最新文献

Identification of CRTH2 as a New PPARγ-Target Gene in T Cells Suggested CRTH2 Dependent Conversion of T_h2 Cells as Therapeutic Concept in COVID-19 Infection. Causality Between 91 Circulating Inflammatory Proteins and Various Asthma Phenotypes: A Mendelian Randomization Study. The Effect of Circulating Inflammatory Proteins on Endometriosis: A Mendelian Randomization Study. Patients with Extensive-Stage Small Cell Lung Cancer Harboring Less Than 4 Metastatic Sites May Benefit from Immune Checkpoint Inhibitor Rechallenge by Reshaping Tumor Microenvironment. The Efficacy and Safety of Bevacizumab Plus Anti-PD-1/PD-L1 Inhibitors in Combination with Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma.